GSK has struck the collaboration to accelerate development of RNA-based therapies for neurodegenerative and renal disorders.

Study shows DAAs and interferon offer similar long-term protection against hepatocellular carcinoma after hepatitis C cure ...

Community oncology study shows the feasibility of offering acupuncture and massage to minority patients traditionally lacking ...

Find out more about a revised digital health literacy scale and what it means for equitable digital health care.

A narrative review highlights flexible abrocitinib treatment for moderate-to-severe atopic dermatitis, emphasizing lowest ...

Global meta-analysis highlights nutrient differences and growth patterns in vegetarian and vegan versus omnivorous diets.

Several widely used food preservatives have been linked to a higher risk of cancer according to a large French study.

JAK inhibitors have expanded options for managing alopecia areata, but questions remain around patient selection, monitoring, ...

Many people living with focal onset seizures (FOS) fail to achieve seizure freedom, even after taking two or more ...

WHO’s review of studies from 2010–2025 confirms vaccines, including thiomersal-containing ones, are not associated with ...

Test your pharma knowledge by playing our Quiz of the Year! Explore the headlines, deals and therapeutic advances that defined 2025.

Disclaimer: Trastuzumab deruxtecan has not been approved by the FDA for the neoadjuvant or adjuvant setting for early-stage, ...